AACR 2018 discussion on brain metastasis phenotyping using a blood brain barrier on a chip
The University of Michigan released a discussion between the press staff and Dr. Oliver discussing the blood brain barrier on a chip device developed with Professors Merajver and Takayama. The potential of this platform may aid in precision phenotyping of cancer cells both prior and after diagnosis of brain metastasis enabling tailoring of the therapeutics and treatment given to a patient.
Ryan Oliver from @sofiamerajver lab describes a microfluidic device and algorithm to predict brain mets #AACR18 https://t.co/lEIMPl9Amx pic.twitter.com/alMkiZhLdo
— U-M Rogel Cancer Center (@UMRogelCancer) April 17, 2018
Dr. Oliver at AACR 2018.